Evidence map›Paper›PMID 35198385›Full record

ArticleIDCases2022

A case of

U Khan, G Tchomobe, S Vakharia, M Suryadevara, S Nagarakanti

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in IDCases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

U KhanDepartment of Internal Medicine, Rutgers - RWJBH Newark Beth Israel Medical Center, Newark NJ, United States.
G TchomobeDepartment of Internal Medicine, Rutgers - RWJBH Newark Beth Israel Medical Center, Newark NJ, United States.
S VakhariaDepartment of Internal Medicine, Rutgers - RWJBH Newark Beth Israel Medical Center, Newark NJ, United States.
M SuryadevaraDepartment of Infectious Disease, Rutgers - RWJBH Newark Beth Israel Medical Center, Newark, NJ, United States.
S NagarakantiDepartment of Infectious Disease, Rutgers - RWJBH Newark Beth Israel Medical Center, Newark, NJ, United States.
Rutgers, The State University of New Jersey · USNewark Beth Israel Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Strongyloidiasis is endemic in tropical and sub-tropical regions however cases of strongyloidiasis have been reported in temperate climates. Corticosteroid use, immunosuppression, infection with human T-lymphotropic virus type 1 (HTLV1), and chronic alcohol use are the most common and well-established risk factors for strongyloidiasis. Due to

Indexed as

DisseminationDuodenitisHTLV 1HyperinfectionStrongyloidiasis

Identifiers

PMID35198385
PMCPMC8844764
OpenAlexW4210551544

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.